Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v13-FR
Language French French
Date Updated 2022-11-16 2022-10-27
Drug Identification Number 02242275 02242275
Brand name TIMOLOL MALEATE-EX TIMOLOL MALEATE-EX
Common or Proper name TIMOLOL TIMOLOL
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients TIMOLOL TIMOLOL
Strength(s) 0.25% 0.25%
Dosage form(s) SOLUTION (EXTENDED RELEASE) SOLUTION (EXTENDED RELEASE)
Route of administration OPHTHALMIC OPHTHALMIC OPHTHALMIC OPHTHALMIC
Packaging size 5ML EGEL 5ML EGEL
ATC code S01ED S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-06-22 2022-06-22
Estimated end date 2022-11-18 2022-11-18
Actual end date 2022-11-16
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments